Pfizer and partner BioNTech asked U.S. health regulators to authorize three doses of their vaccine for children under 5 years.
Pfizer Inc. and partner BioNTech SE asked U.S. health regulators to authorize three doses of their vaccine for children under 5 years.
The Pfizer PFE, -1.26% -BioNTech BNTX, -1.14% vaccine was also found to be safe and well-tolerated among the children in studies, according to the companies.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut: